SalioGen Therapeutics Announces Data Presentation at Association for Research in Vision and Ophthalmology (ARVO) and American Society for Gene and Cell Therapy (ASGCT) 2024 Annual Meetings
–Company to provide preclinical data for SGT-1001, development candidate for Stargardt disease — –New in vitro data demonstrate site-specific integration CFTRa potential mutation-agnostic cystic fibrosis treatment — Lexington, Massachusetts, April …
